Clinical Trial Update: Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML) [EARLY_Phase 1]

View source ↗

Summary

This early-phase (Phase 1) clinical trial update reports completion of a study evaluating CD7-targeted CAR-T cell therapy in patients with relapsed/refractory C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• T-cell Acute Lymphoblastic Leukemia
• T-lymphoblastic Lymphoma

Drugs mentioned

• CD7-targeted CAR-T cell therapy (CD7-directed chimeric antigen receptor T-cell therapy)

Snippet

Sponsor: Kai Lin Xu，MD | Conditions: Neoplasms, Hematologic Neoplasms | EARLY_Phase 1 | Status: COMPLETED